Literature DB >> 2584342

Gas chromatographic-mass spectrometric analysis of threo-methylphenidate enantiomers in plasma.

T Aoyama1, H Kotaki, Y Saitoh.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2584342     DOI: 10.1016/s0378-4347(00)82698-5

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats.

Authors:  T Aoyama; H Kotaki; Y Sawada; T Iga
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  Nonlinear kinetics of threo-methylphenidate enantiomers in a patient with narcolepsy and in healthy volunteers.

Authors:  T Aoyama; H Kotaki; T Sasaki; Y Sawada; Y Honda; T Iga
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Enantioselective pharmacokinetics of dl-threo-methylphenidate in humans.

Authors:  N R Srinivas; J W Hubbard; E D Korchinski; K K Midha
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

Review 4.  Ethylphenidate as a selective dopaminergic agonist and methylphenidate-ethanol transesterification biomarker.

Authors:  Kennerly S Patrick; Timothy R Corbin; Cristina E Murphy
Journal:  J Pharm Sci       Date:  2014-10-09       Impact factor: 3.534

5.  Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites.

Authors:  T Aoyama; H Kotaki; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.